Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
HOUSTON, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare...
-
BEIJING, Oct. 04, 2024 (GLOBE NEWSWIRE) -- BingEx Limited (“BingEx” or the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier services provider in China (branded as “FlashEx”), today...
-
ORLANDO, Fla., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Innventure, Inc. (Nasdaq: INV) and Learn CW Investment Corporation (NASDAQ: LCW) (“Learn CW”), a special purpose acquisition company, today announced...
-
SINGAPORE, Oct. 02, 2024 (GLOBE NEWSWIRE) -- HomesToLife Ltd. (“HTLM” or the “Company”) today announced the closing of its previously announced initial public offering of an aggregate of 1,437,500...
-
RICHMOND, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic...
-
CALGARY, Alberta, Oct. 01, 2024 (GLOBE NEWSWIRE) -- South Bow Corporation (South Bow) is launching as an independent company after completing its planned separation from TC Energy Corporation (TC...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...
-
RICHMOND, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic...
-
Saga is pleased to announce the successful closing of its IPO and provide updates on its major projects. SAGA shares are now trading on the TSXV.
-
Saga Metals Corp. is pleased to announce the successful closing of its initial public offering for gross proceeds of $1,758,500 and listing on the TSXV.